Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors

Clinical trial NCT07492693 · RECRUITING

Trial details

NCT number: NCT07492693
Sponsor: Changhai Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors

Start date: 2024-10-01
Primary completion: 2026-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.